Analytical Lens: Exploring Sangamo Therapeutics Inc (SGMO)’s Financial Story Through Ratios

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Sangamo Therapeutics Inc (NASDAQ: SGMO) was $2.71 for the day, up 0.37% from the previous closing price of $2.70. In other words, the price has increased by $0.37 from its previous closing price. On the day, 8.37 million shares were traded. SGMO stock price reached its highest trading level at $2.86 during the session, while it also had its lowest trading level at $2.44.

Ratios:

Our analysis of SGMO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 1.03. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 1.23.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on November 03, 2023, Downgraded its rating to Sector Perform and sets its target price to $2 from $6 previously.

On April 28, 2023, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $5 to $1.50.

Wedbush Upgraded its Neutral to Outperform on February 27, 2023, while the target price for the stock was maintained at $16.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMO now has a Market Capitalization of 564278912 and an Enterprise Value of 565588992. For the stock, the TTM Price-to-Sale (P/S) ratio is 45.95 while its Price-to-Book (P/B) ratio in mrq is 23.82. Its current Enterprise Value per Revenue stands at 46.069 whereas that against EBITDA is -3.057.

Stock Price History:

Over the past 52 weeks, SGMO has reached a high of $3.18, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is 118.88%, while the 200-Day Moving Average is calculated to be 235.01%.

Shares Statistics:

SGMO traded an average of 7.21M shares per day over the past three months and 10749980 shares per day over the past ten days. A total of 208.22M shares are outstanding, with a floating share count of 198.63M. Insiders hold about 4.60% of the company’s shares, while institutions hold 40.62% stake in the company. Shares short for SGMO as of 1728950400 were 18220713 with a Short Ratio of 2.63, compared to 1726185600 on 17504104. Therefore, it implies a Short% of Shares Outstanding of 18220713 and a Short% of Float of 8.799999999999999.

Most Popular